Related Experiment Video
Updated: Jan 7, 2026

07:49
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
19.9K
De-Labelling Penicillin Allergies in the Paediatric Emergency Department.
Owen Hibberd1,2, Spyridon Karageorgos2,3, Melanie Ranaweera4
1Emergency and Urgent Care Research in Cambridge (EURECA), PACE Section, Department of Medicine, Cambridge University, Cambridge CB2 0QQ, UK.
Antibiotics (Basel, Switzerland)
|December 30, 2025
Summary
Most children labeled with penicillin allergy are not truly allergic. Penicillin de-labeling in pediatric emergency departments (PEDs) is feasible and effective, reducing antibiotic overuse and improving outcomes.
Area of Science:
- Pediatric Allergy and Immunology
- Antimicrobial Stewardship
- Clinical Pharmacology
Background:
- A significant number of pediatric patients carry a penicillin allergy label, but most lack true hypersensitivity.
- This label contributes to unnecessary broad-spectrum antibiotic use, increased healthcare expenses, and suboptimal patient outcomes.
Purpose of the Study:
- To review penicillin allergy types, de-labeling strategies, and their impact on pediatric patients.
- To explore parental views on penicillin de-labeling within emergency settings.
- To assess the feasibility and effectiveness of penicillin de-labeling in pediatric emergency departments (PEDs).
Main Methods:
- Literature review on penicillin allergy classification and de-labeling approaches.
- Analysis of the significance of penicillin allergy labels in pediatric populations.
- Discussion of parental perspectives and challenges in the emergency setting.
Main Results:
- The pediatric emergency department (PED) is identified as an optimal setting for penicillin de-labeling due to available resources and expertise.
- Despite challenges like overcrowding, penicillin de-labeling in PEDs can be both feasible and effective.
- Education for parents and healthcare professionals is crucial for addressing misconceptions and safety concerns.
Conclusions:
- Penicillin de-labeling in pediatric patients is essential for reducing reliance on broad-spectrum antibiotics and improving clinical outcomes.
- The PED environment presents unique opportunities for successful penicillin de-labeling.
- Enhanced education and trust-building are key to normalizing penicillin de-labeling practices.
Related Concept Videos
Allergic Reactions
31.9K
Overview
31.9K
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion
191
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
191
Drug Dosing: Infants and Children
229
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
229

